Jacques Brom is the Chief Executive Officer of LFB, a state-owned French company specializing in plasma-derived medicines.
Jacques Brom is the Chief Executive Officer of LFB, a state-owned French company specializing in plasma-derived medicines. LFB focuses on treating patients in France using plasma collected within the country, with an annual turnover of approximately EUR 550 million. The company is currently undergoing a significant growth phase, including a EUR 750 million investment in a new industrial facility in Arras, France, to triple its plasma fractionation capacity by 2030.
Full founder directory · Investor directory · Company funding database · Fundraising library